Evernow LegitScript and Accreditation Status: What Patients Need to Know

What Is LegitScript and Why Does It Matter for Telehealth?

LegitScript is an independent certification and monitoring organization that verifies whether online healthcare and pharmacy operations comply with applicable laws and regulations. Its certification is required for telehealth brands to run paid advertising on Google and Meta, making it a practical proxy for regulatory compliance. A brand without LegitScript certification is not necessarily operating illegally, but the absence of that credential means its compliance posture has not been independently audited by that body.

The FDA's framework for online pharmacy oversight relies partly on voluntary accreditation programs. The National Association of Boards of Pharmacy (NABP) runs a parallel program called ".pharmacy" accreditation and maintains a "Not Recommended" list of online pharmacies that fail safety standards. Neither LegitScript nor NABP accreditation is legally mandatory for a telehealth platform that prescribes through separately licensed pharmacies, but their absence is a data point worth weighing.

How LegitScript Certification Works

LegitScript reviews applicants against its Healthcare Merchant Standards, which include verification of prescriber licensure, pharmacy accreditation, and prescription-only drug dispensing policies. Certified merchants are listed in LegitScript's public database. A search of that database in January 2025 returned no active certification record for Evernow.

What the Absence of Certification Means Practically

The lack of a LegitScript credential does not mean Evernow's prescribers are unlicensed or that its drugs are counterfeit. It means the platform has not completed, or has not published completion of, that third-party audit. Patients relying on LegitScript as a trust signal will find no confirmation here. Those evaluating Evernow should instead look directly at state medical board licensure for each prescribing clinician, which is publicly searchable through individual state licensing databases.

Evernow's Clinical Focus: Menopause Hormone Therapy

Evernow markets itself as a menopause-specialist telehealth platform, offering FDA-approved estradiol and progesterone products. This is clinically grounded territory. The 2023 Menopause Society (formerly NAMS) position statement affirms that hormone therapy is the most effective treatment for vasomotor symptoms and that for women under 60 or within 10 years of menopause onset, the benefits of HRT generally outweigh the risks for appropriately selected candidates. [1]

The drugs Evernow prescribes, such as oral estradiol, transdermal estradiol patches, and micronized progesterone (Prometrium), all carry FDA approval. Oral micronized progesterone was approved by the FDA and its prescribing information is publicly available on FDA's accessdata portal. [2] Transdermal estradiol systems are similarly FDA-regulated. [3]

Clinical Guidelines Supporting Menopause HRT

The Menopause Society's 2023 statement, endorsed by 20 medical organizations, states: "Hormone therapy remains the most effective treatment for vasomotor symptoms and genitourinary syndrome of menopause and has been shown to prevent bone loss and fracture." [1] The American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin No. 141 similarly supports individualized HRT for symptomatic menopause. [4]

A 2022 re-analysis of the Women's Health Initiative data published in JAMA found that conjugated equine estrogen plus medroxyprogesterone acetate was associated with a 0.09% absolute increase in breast cancer incidence over 5.6 years of follow-up, a figure that must be weighed against symptom burden and individual risk profile. [5] Evernow's prescribing protocols should reflect this nuanced benefit-risk calculus.

Compounded vs. FDA-Approved Medications

The FDA has issued repeated guidance warning against compounded bioidentical hormone therapy, noting that such preparations lack the safety and efficacy data of FDA-approved products. [6] Evernow's public-facing materials indicate a focus on FDA-approved formulations, which aligns with both ACOG and Menopause Society recommendations. Patients should ask, in writing, whether any prescribed product is compounded, and if so, whether it comes from an FDA-registered outsourcing facility under Section 503B of the Federal Food, Drug, and Cosmetic Act. [7]

Is Evernow Legit? Licensing and Regulatory Standing

"Legit" in a regulatory sense means that prescribers hold active, unrestricted licenses in the states where they practice, that the platform collects a valid medical history before prescribing, and that controlled substances (if any) are handled per DEA rules. On these dimensions, Evernow can be evaluated through public records.

Prescriber Licensure

Each clinician on a telehealth platform must hold an active license in the patient's state of residence. State medical board databases are free to search. For example, the Federation of State Medical Boards offers a centralized lookup. Patients should verify their assigned provider's license before their first visit. Evernow's website states that patients are matched with licensed clinicians, but the platform does not publish a full roster with license numbers, which makes independent verification require a step from the patient.

Telehealth Prescribing Rules Post-COVID

The DEA's 2023 proposed rule on telemedicine prescribing of controlled substances would require an in-person visit before prescribing Schedule III-V drugs without a special registration. [8] HRT medications including estradiol and progesterone are not scheduled controlled substances, so this rule does not directly restrict Evernow's core prescribing activity. Still, any platform treating menopause patients who also require low-dose testosterone therapy (an off-label but guideline-discussed option) would need to comply with controlled-substance telemedicine rules.

State Availability Gaps

Evernow's enrollment page lists states where it does not operate. These exclusions typically reflect the absence of a licensed prescriber in that state or restrictions on telehealth prescribing in that jurisdiction. Patients in unsupported states who attempt to enroll may receive no service despite completing intake forms, a friction point reflected in some consumer complaints.

Evernow Complaints: What the Consumer Record Shows

Consumer complaint data comes from three main public sources: the Better Business Bureau (BBB), Trustpilot, and state attorney general complaint databases. A structured review of these sources reveals a pattern worth examining.

Better Business Bureau Profile

The BBB lists Evernow with complaints in the billing and service categories. Common themes in the complaint text include: difficulty reaching customer support after subscription charges, unexpected auto-renewal fees, and delays in prescription processing. The BBB complaint resolution rate for Evernow shows some cases closed with company response and some closed without satisfactory resolution, based on the public file as of January 2025. Patients should review the BBB profile for Evernow directly before subscribing, as the complaint count and resolution status update continuously.

Billing transparency is a specific concern the FDA and FTC have addressed in broader telehealth contexts. The FTC's 2023 enforcement actions against deceptive subscription practices in health services set a precedent for consumer protections in this space. [9]

Trustpilot and App Store Reviews

Across third-party review platforms, Evernow receives mixed scores. Positive reviews cite convenient async messaging, knowledgeable providers, and faster access to HRT than traditional OB/GYN waitlists. Negative reviews focus on cancellation difficulty, delayed responses from the clinical team, and confusion about which pharmacy will fill the prescription. These are operational complaints rather than clinical safety events, but they affect the patient experience materially.

How to File a Complaint

Patients with unresolved concerns have several avenues. The state medical board in the prescribing clinician's state handles complaints about clinical care. The FDA's MedWatch program accepts reports of adverse drug events. [10] The FTC accepts reports about deceptive billing at reportfraud.ftc.gov. Each of these channels creates a public record that regulators use to prioritize enforcement.

Pharmacy Fulfillment and Drug Safety

Evernow routes prescriptions through third-party pharmacies. The safety of the dispensed medication depends on the accreditation status of that pharmacy, not just Evernow's own compliance posture.

What to Ask About Your Pharmacy

Patients should confirm whether their assigned pharmacy holds NABP accreditation or a state board of pharmacy license in their state. The NABP's Verified Internet Pharmacy Practice Sites (VIPPS) program is the gold standard for online pharmacy verification. [11] A pharmacy dispensing FDA-approved estradiol from a VIPPS-accredited facility presents a materially lower risk profile than one operating without that credential.

503B Outsourcing Facilities

If any prescribed hormone product is compounded, patients should ask whether it originates from a 503B-registered outsourcing facility. The FDA maintains a public list of registered 503B facilities. [12] Products from 503A compounding pharmacies (which compound for individual patients) are legal but carry no FDA review of safety or potency data. The FDA has specifically flagged custom compounded bioidentical hormones as lacking evidence of safety or efficacy equivalence to approved products. [6]

Comparing Evernow's Accreditation Profile to Competitors

Several menopause and HRT telehealth competitors hold credentials that Evernow currently lacks in the public record. Midi Health, Alloy, and Gennev (now acquired by Unified Women's Healthcare) each maintain varying levels of public credentialing documentation. The absence of a LegitScript record does not make Evernow uniquely non-compliant, but patients making a comparative decision deserve to know that the credential gap exists.

The URAC Telehealth Accreditation Standard

URAC offers a telehealth accreditation that covers clinical quality, patient safety, and operational standards. [13] As of January 2025, Evernow does not list a URAC accreditation on its website. URAC-accredited telehealth organizations undergo triennial reviews covering credentialing of providers, clinical protocols, and quality improvement programs. Patients who prioritize independently audited clinical quality standards may find URAC accreditation a more clinically meaningful credential than LegitScript alone.

The Joint Commission

The Joint Commission accredits ambulatory care organizations, including some telehealth-first entities. [14] Evernow does not appear on The Joint Commission's public list of accredited organizations as of January 2025. This is not unusual for early-stage telehealth companies, but it is a data point for patients comparing platforms.

What Good Menopause Telehealth Looks Like: A Verification Checklist

Patients evaluating any menopause telehealth platform, including Evernow, should work through a concrete checklist before submitting payment information.

Prescriber Verification Steps

First, ask for the full name and state license number of the clinician who will prescribe your medication. Run that license through the relevant state medical board database and confirm the license is active and has no public disciplinary actions. The FSMB DocInfo tool aggregates license records from 40+ states. [15]

Second, confirm the platform has a synchronous visit option before prescribing HRT for the first time. A 2022 ACOG committee opinion on telehealth states that "an initial in-person examination may be appropriate depending on the clinical circumstance," and the Menopause Society recommends individualized assessment before initiating therapy. [4] Async-only intake for complex HRT regimens may not meet the standard of care in every jurisdiction.

Pharmacy Verification Steps

Confirm the dispensing pharmacy's name and look it up in the NABP VIPPS directory. [11] If it does not appear there, search the state board of pharmacy in the pharmacy's operating state. Ask explicitly whether any product is compounded, and if so, request the name of the compounding facility and its 503B registration number or state license number.

Billing and Cancellation Verification Steps

Read the cancellation and refund policy before entering payment information. The FTC's Negative Option Rule, updated in 2023, requires clear disclosure of recurring charges and a simple cancellation mechanism. [9] Screenshot the policy at enrollment. If Evernow's billing terms change after enrollment, having a dated screenshot creates documentation for a chargeback or FTC complaint if needed.

Evernow's Clinical Protocol: Strengths and Gaps

On the clinical side, Evernow's publicly available protocol information indicates that it uses symptom questionnaires and medical history intake before prescribing. This aligns with the Menopause Society's guidance that treatment decisions should be based on symptom burden and individual risk assessment. [1]

Hormone Level Testing

The Menopause Society's 2023 position statement notes that routine hormone level testing (FSH, estradiol) is not required to diagnose menopause in women over 45 with typical symptoms, but testing may clarify the picture in atypical presentations or women under 45. [1] Evernow's intake process, based on publicly available information, appears to rely primarily on symptom questionnaires rather than requiring lab work for all patients. This is consistent with guideline recommendations for typical presentations, but patients with atypical symptoms or early-onset perimenopause should ask whether lab evaluation is available through the platform.

Cardiovascular and Thrombosis Risk Screening

ACOG and the Menopause Society both recommend screening for cardiovascular disease risk factors, personal and family history of venous thromboembolism (VTE), and contraindications to estrogen before initiating HRT. [4] Oral estradiol increases VTE risk more than transdermal estradiol, a distinction supported by a 2019 BMJ study (N=80,396) that found oral HRT was associated with a higher VTE risk (odds ratio 1.58, 95% CI 1.25-2.00) compared with transdermal HRT (odds ratio 0.93, 95% CI 0.73-1.19). [16] A platform prescribing oral estradiol without screening for VTE risk would not meet this standard.

Follow-Up and Monitoring

The Menopause Society recommends annual reassessment of HRT, including symptom control, blood pressure, and breast health. [1] Patients using any telehealth platform for ongoing HRT should confirm that the platform has a structured annual review process, not just reactive messaging when symptoms change.

Summary of Verification Actions for Evernow Patients

Patients considering Evernow should take these specific steps before and after enrollment.

Before enrollment: search the LegitScript certification database directly; verify the assigned prescriber's license through FSMB DocInfo or the relevant state board; confirm the dispensing pharmacy's NABP VIPPS status; read the cancellation policy in full and document it.

After enrollment: request the full name of your dispensing pharmacy and verify it independently; ask in writing whether any prescribed product is compounded and from which facility; schedule an annual reassessment visit and document that it occurred.

Patients in states not served by Evernow can access guideline-concordant menopause care through their OB/GYN or a certified menopause practitioner listed on the Menopause Society's provider directory. [1]

The single most actionable step for a patient evaluating Evernow today: run the prescriber's name and state through the FSMB DocInfo database at fsmb.org before submitting any payment, and confirm the license shows "active" with no disciplinary flag.